Capstone Investment Advisors
BNTX icon

Capstone Investment Advisors’s BioNTech BNTX Stock Holding History

Capstone Investment Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,500
Closed -$238K – 1607
2025
Q4 		$238K Buy
+2,500
New +$252K ﹤0.01% 1449

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Investment Advisors's BNTX Position: Q2 2025 in Review

Capstone Investment Advisors sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 4,050 shares — an estimated $369K sold.

Capstone Investment Advisors first reported a position in BNTX in Q1 2024 and held it in 4 quarters. The position peaked at $777K in Q3 2024. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Capstone Investment Advisors reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 4,050 BioNTech shares in Q2 2025, an estimated $369K.
  • Capstone Investment Advisors first reported a position in BioNTech in Q1 2024 and held it in 4 quarters.
  • Capstone Investment Advisors's BioNTech position peaked at $777K in Q3 2024.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Capstone Investment Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.